News

Back

Ctrl-BBB: a brain filter

January 30th 2020

Communication Recherche ULB

Ctrl-BBB, a project led by Benoit Vanhollebeke, an investigator for WELBIO at the Neurovascular Signalling Laboratory (Faculty of Sciences, BioPark and ULB Neuroscience Institute). Its goal is to study the complex regulation of the blood-brain barrier, which supplies the brain with oxygen and nutrients while also keeping out potentially toxic cells and compounds as well as drugs.

 

Blood vessels in the brain act as filters: they supply oxygen and nutrients to the brain, while also keeping out potentially toxic cells and compounds. The blood-brain barrier (BBB) fulfils this dual role and ensures cerebral homoeostasis.

 

With his ERC Consolidator project, dubbed ‘Ctrl-BBB’, Benoit Vanhollebeke—an investigator for WELBIO at the Neurovascular Signalling Laboratory (Faculty of Sciences, BioPark and ULB Neuroscience Institute)—will study the complex regulation mechanisms of this barrier. These are not the result of genetic programming, but rather of multiple interactions between endothelial cells in blood vessels and other components of the neurovascular system. Over the past few years, Benoit Vanhollebeke and his team have developed new models that enable a non-invasive genetic analysis of the blood-brain barrier’s functions.

 

‘Understanding the BBB’s regulation is essential in order to understand dysfunctions associated with many cerebrovascular conditions (stroke, glioblastoma, neurodegenerative diseases). It would also enable us to look into new therapeutic approaches: the BBB remains the main obstacle to getting drugs into the central nervous system’, explains Benoit Vanhollebeke.

 

 

This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 865176).